Condition: Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Intervention: Drug: SRA737
Sponsor: Sierra Oncology, Inc.
Recruiting - verified April 2017
from #ORL via a.lsfakia on Inoreader http://ift.tt/2qI3edW
via IFTTT
http://ift.tt/2pOxxQr
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Does formal research training lead to academic success in otolaryngology? : Objectives/Hypothesis To evaluate whether formalized researc...
-
Abstract The powerful method of eigenfunction superposition is applied to the starting flow in a sector duct filled with a porous medium. ...
-
Computed tomography-guided percutaneous microwave ablation: A new weapon to treat ground-glass opacity–lung adenocarcinoma Yancu Hertzanu, X...
-
Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man The original article can be found...
-
Visual impairment in kurdistan and trend of epidemiologic eye studies in Iran Per Kallestrup Journal of Ophthalmic and Vision Research 2019 ...
-
Researchers found that hearing loss, hospitalizations, and decreases in verbal fluency are associated with cognitive decline. These finding...
-
The aims of this study were to investigate temporal patterns and potential risk factors for severe hyposalivation (xerostomia) after intensi...
-
Lymphangitic carcinomatosis Publication date: Available online 21 May 2019 Source: Current Medicine Research and Practice Author(s): Dr She...
-
A novel contact-independent T6SS that maintains redox homeostasis via Zn 2+ and Mn 2+ acquisition is conserved in the Burkholderia pseudo...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου